Health
1,000 UK doctors condemn medical association’s push to lift puberty blocker ban for minors
From LifeSiteNews
1,000 senior doctors signed an open letter to the British Medical Association after it lobbied for the NHS to lift a ban on puberty blockers for children following the Cass Review, which found the drugs were harmful.
On August 1, the British Medical Association (BMA) – the United Kingdom’s doctors’ union – called on the government to lift the ban on puberty blockers for minors. Weirdly, the BMA also stated that in their view the implementation of NHS England’s Cass Review should be “paused” despite the fact that, as the BBC noted, the review “took four years to carry out and was widely welcomed by the medical establishment in the U.K.” The BMA called the Cass Review’s recommendations – based on “the largest and most comprehensive review” on the subject seen, looking at 237 papers from 18 countries – “unsubstantiated.”
A spokesperson for the Department of Health and Social Care responded to the BMA, firmly rejecting both the request and the claim, stating, “The Cass Review is a robust report backed by clinicians and firmly grounded in evidence. NHS England will be implementing Dr. Cass’s recommendations so that children and young people get the safe, holistic support they need. We do not support a delay to vital improvements from the NHS to gender services.” Even the leftist Guardian ran an editorial criticizing the BMA’s position, stating, “The BMA’s stance on puberty blockers defies the key principle of medicine: first, do no harm.”
READ: FDA official recommends approval of puberty blockers despite suicide risk for gender-confused youth
As it turns out, there are plenty of physicians who are very unhappy with the BMA’s move – and they are now making their voices heard. This week, 1,000 senior doctors from across the U.K. published an open letter addressed to Professor Philip Banfield, chairman of the BMA.
“We write as doctors to say, ‘not in my name,’” the letter reads. “We are extremely disappointed that the BMA council had passed a motion to conduct a ‘critique’ of the Cass Review and to lobby to oppose its recommendations. The passing of the motion was opaque and secretive. It does not reflect the views of the wider membership, whose opinion you did not seek. We understand that no information will be released on the voting figures and how council members voted. That is a failure of accountability to members and is simply not acceptable.”
The open letter further emphasizes that the Cass Review “is the most comprehensive review into healthcare for children with gender related distress ever conducted” and urged the BMA to “abandon its pointless exercise” of attacking and opposing the recommendations. “By lobbying against the best evidence we have, the BMA is going against the principles of evidence-based medicine and against ethical practice.”
Among the signatories to the letter are 23 former or current clinical leaders at royal colleges, as well as the heads and former heads of some royal colleges.
The British Medical Association is the only main medical organization to oppose the Cass Review; all others have backed it. For example, Professor Sir Stephen Powis, NHS national medical director, stated, “These plans set out in detail how we will establish a fundamentally different and safer model of care for children and young people. The work Dr. Cass has undertaken has been invaluable in helping us shape the new service offer, and we have already begun our transformation of these services by opening two new regional centres this year.” Banfield responded on behalf of the BMA council to say that the points made in the letter would be considered during their ongoing evaluation.
As Josephine Bartosch observed, “it is becoming increasingly clear that the BMA is dangerously out of step with the medical consensus. The Cass Review has sent ripples across the world, and from lawsuits in the U.S. to a change of tack across Europe – medics are increasingly acknowledging that what is a crisis in youth mental health cannot be cured by changing bodies.”
The Red Deer Regional Health Foundation is thrilled to announce the winners of this year’s Red Deer Hospital Lottery prizes – including the Dream Home, a $100,000.00 cash prize, and Mega Bucks 50.
James Smith of Spruce View has won the $100,000.00 cash prize.
Montey Brehaut of Red Deer has won the Mega Bucks 50 jackpot, taking home $301,702.50.
The grand prize Sorento Custom Homes Dream Home, including furnishings by Urban Barn and worth $1,074,472 – has been awarded to Oscar Gunnlaugson of Sylvan Lake.
The winner announcements took place at noon on June 26 , 2025 – and was streamed live on Facebook from Red Deer Regional Hospital Center.
“We’re excited to celebrate this year’s winners and deeply grateful to everyone who supported the lottery,” said Manon Therriault, CEO of the Red Deer Regional Health Foundation. “Funds raised will directly enhance patient care at Red Deer Regional Hospital Centre.”
This year’s lottery proceeds will fund essential new and replacement equipment, ensuring Red Deer Regional Hospital Center can continue to serve the 500,000 people who rely on it. While plans for the hospital expansion move forward, healthcare doesn’t wait. Patients in our community need access
to life-saving technology today, and supporting Red Deer Hospital Lottery has made that possible.
A full list of winners, including electronics prize recipients, will be posted on July 2 at reddeerhospitallottery.ca.
Winners will also receive instructions on how to claim their prizes by mail.
The keys to the Dream Home will be presented at a special ceremony this summer.
From LifeSiteNews
Research found that men who underwent a ‘gender transition’ using hormones have a 51% higher mortality rate than the general population and a ‘threefold’ greater risk of cardiovascular deaths.
A newly published study has found that males’ use of estrogen to present as “female” triples their risk of cardiovascular disease, while also heightening the risk of stroke, blood clots, depression, and cognitive impairment.
The journal Discover Mental Health on June 12 released a variety of findings regarding the negative impacts of estrogen use in males attempting to transition to “female.” One of the most significant was that current estrogen use “was associated with a threefold increased risk of death from cardiovascular events.”
In fact, a study of 966 “female transitioned” males were found to have a mortality rate 51 percent higher than that of the general population. Their main causes of death included cardiovascular disease (21 percent), cancer (32 percent), suicide (7.5 percent), and infection-related disease (five percent).
Estrogen use by males amplified other cardiovascular risks, especially with prolonged use. One meta-analysis found a 30 percent higher rate of stroke among gender-confused men who took estrogen compared with men who did not.
A review also found “strong evidence” that estrogen use by men increases their risk for vein blood clots “over fivefold.”
Estrogen use was also found to have a detrimental cognitive impact on men. For example, so-called “female transitioned” males were found to have lower scores than both their other male counterparts and women in “information-processing speed and episodic memory.”
In addition, elevated symptoms of depression were “associated with increased serum levels of estradiol” for men under the age of 60.
This recent study confirms 2023 study that found that all gender-confused individuals, whether men attempting to present themselves as women or women attempting to present themselves as men, were at significantly increased risk for a range of deadly cardiovascular conditions, including strokes, heart attacks, high blood pressure, and elevated cholesterol levels.
A 2019 study published by the National Institutes of Health (NIH) National Library of Medicine also found:
Cardiovascular disease (CVD) is the leading disease-specific cause of death for [so-called] transgender people undergoing [transgender procedures], with only suicide claiming more lives as the leader of all cause mortality.
However, for [gender-confused males], the risk of death from CVD is 3-fold higher than for all other groups.
Research reported by both the British Heart Association and the American Heart Association that same year arrived at similar findings:
“We already know sex hormones are important to cardiovascular health, and now we have people being exposed to high levels of sex hormones they normally would not have, which could be associated with cardiovascular benefit or risk,” said Dr. Christian Delles, a professor at the Institute of Cardiovascular and Medical Sciences at the University of Glasgow.
Trump’s Strike on Iran Reshapes Global Power Balance, Deals First Blow to Beijing and CRINK Axis
Preston Manning: “Appearing to Cope” – Is This The Best We Can Do?
Energy Policies Based on Reality, Not Ideology, are Needed to Attract Canadian ‘Superpower’ Level Investment – Ron Wallace
High Taxes Hobble Canadian NHL Teams In Race For Top Players
-
MAiD9 hours agoCanada’s euthanasia regime is not health care, but a death machine for the unwanted
-
COVID-191 day agoOntario man launches new challenge against province’s latest attempt to ban free expression on roadside billboards
-
Business1 day agoFederal government should finally cut Trudeau-era red tape
-
Business8 hours agoOttawa Funded the China Ferry Deal—Then Pretended to Oppose It
-
Alberta1 day agoCanadian Oil Sands Production Expected to Reach All-time Highs this Year Despite Lower Oil Prices
-
Business1 day agoTaxpayers Federation presents Teddy Waste Awards for worst government waste
-
International1 day agoPresident Xi Skips Key Summit, Adding Fuel to Ebbing Power Theories
-
armed forces6 hours agoMark Carney Thinks He’s Cinderella At The Ball